Real-time imaging of the epithelial-mesenchymal transition using microRNA-200a sequence-based molecular beacon-conjugated magnetic nanoparticles

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Choi, YoonSeok ^a,b   Kim, Hoe Suk ^a,b   Woo, Jisu ^b   Hwang, Eun Hye ^b   Cho, Kyoung Won ^a,b   Kim, Soonhag ^c   Moon, Woo Kyung ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETIC NANOPARTICLE; MICRORNA 200A; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA1; MAGNETITE NANOPARTICLE; MICRORNA; MIRN200 MICRORNA, HUMAN;

ANIMAL CELL; ARTICLE; BIOLOGICAL MONITORING; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL LOSS; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FLUORESCENCE IMAGING; GENE EXPRESSION; HUMAN; HUMAN CELL; MATERIAL COATING; MESENCHYME; MOLECULAR BEACON; MOLECULAR IMAGING; NONHUMAN; PROTEIN RNA BINDING; RNA SEQUENCE; SIGNAL DETECTION; ANIMAL; CELL LINE; CHEMISTRY; DIAGNOSTIC USE; DOG; MOUSE; NUCLEOTIDE SEQUENCE; PROCEDURES; TUMOR CELL LINE;

COMPUTER SYSTEMS; GLUTAREDOXINS; GLUTATHIONE; GREEN FLUORESCENT PROTEINS; HUMANS; INTRACELLULAR SPACE; MALARIA, FALCIPARUM; MOLECULAR IMAGING; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLASMODIUM FALCIPARUM; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; ANIMALS; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; DOGS; EPITHELIAL-MESENCHYMAL TRANSITION; MAGNETITE NANOPARTICLES; MICE; MICRORNAS; OPTICAL IMAGING;

EID: 84904646716     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102164     Document Type: Article

References (46)

1. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449.
2. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331: 1559-1564.
3. De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13: 97-110.
4. Eger A, Stockinger A, Schaffhauser B, Beug H, Foisner R (2000) Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J Cell Biol 148: 173-188.
5. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, et al. (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 2375-2385. (Pubitemid 40546696)
6. Gheldof A, Berx G (2013) Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci 116: 317-336.
7. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601. (Pubitemid 351627379)
8. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907. (Pubitemid 351482843)
9. Korpal M, Lee ES, Hu G, Kang Y (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
10. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J (2012) Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22: 725-736.
11. Tsourkas A, Bao G (2003) Shedding light on health and disease using molecular beacons. Brief Funct Genomic Proteomic 1: 372-384.
12. Tan W, Wang K, Drake TJ (2004) Molecular beacons. Curr Opin Chem Biol 8: 547-553. (Pubitemid 39278353)
13. Li Y, Zhou X, Ye D (2008) Molecular beacons: an optimal multifunctional biological probe. Biochem Biophys Res Commun 373: 457-461.
14. Tyagi S, Kramer FR (2012) Molecular beacons in diagnostics. F1000 Med Rep 4: 10.
15. Sokol DL, Zhang X, Lu P, Gewirtz AM (1998) Real time detection of DNA.RNA hybridization in living cells. Proc Natl Acad Sci U S A 95: 11538-11543. (Pubitemid 28460450)
16. Perlette J, Tan W (2001) Real-time monitoring of intracellular mRNA hybridization inside single living cells. Anal Chem 73: 5544-5550. (Pubitemid 33108566)
17. Bratu DP, Cha BJ, Mhlanga MM, Kramer FR, Tyagi S (2003) Visualizing the distribution and transport of mRNAs in living cells. Proc Natl Acad Sci U S A 100: 13308-13313. (Pubitemid 37444738)
18. Peng XH, Cao ZH, Xia JT, Carlson GW, Lewis MM, et al. (2005) Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research. Cancer Res 65: 1909-1917. (Pubitemid 40478620)
19. Bao G, Rhee WJ, Tsourkas A (2009) Fluorescent probes for live-cell RNA detection. Annu Rev Biomed Eng 11: 25-47.
20. Nuovo G, Lee EJ, Lawler S, Godlewski J, Schmittgen T (2009) In situ detection of mature microRNAs by labeled extension on ultramer templates. Biotechniques 46: 115-126.
21. Hwang do W, Song IC, Lee DS, Kim S (2010) Smart magnetic fluorescent nanoparticle imaging probes to monitor microRNAs. Small 6: 81-88.
22. Rodriguez AJ, Condeelis J, Singer RH, Dictenberg JB (2007) Imaging mRNA movement from transcription sites to translation sites. Semin Cell Dev Biol 18: 202-208. (Pubitemid 46756371)
23. Yeh HY, Yates MV, Mulchandani A, Chen W (2008) Visualizing the dynamics of viral replication in living cells via Tat peptide delivery of nuclease-resistant molecular beacons. Proc Natl Acad Sci U S A 105: 17522-17525.
24. Wang W, Cui ZQ, Han H, Zhang ZP, Wei HP, et al. (2008) Imaging and characterizing influenza A virus mRNA transport in living cells. Nucleic Acids Res 36: 4913-4928.
25. Jones R, Baker MB, Weber M, Harrison DG, Bao G, et al. (2009) Molecular beacons can assess changes in expression and 3′-polyadenylation of human eNOS mRNA. Am J Physiol Cell Physiol 296: C498-504.
26. Wang Q, Chen L, Long Y, Tian H, Wu J (2013) Molecular beacons of xenonucleic acid for detecting nucleic acid. Theranostics 3: 395-408.
27. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, et al. (2009) The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc 4: 1591-1613.
28. Scheel C, Weinberg RA (2012) Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22: 396-403.
29. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
30. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829. (Pubitemid 351757205)
31. Oltean S, Febbo PG, Garcia-Blanco MA (2008) Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo. Clin Exp Metastasis 25: 611-619.
32. Somarelli JA, Schaeffer D, Bosma R, Bonano VI, Sohn JW, et al. (2013) Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo. RNA 19: 116-127.
33. Law WC, Mahajan SD, Kopwitthaya A, Reynolds JL, Liu M, et al. (2012) Gene Silencing of Human Neuronal Cells for Drug Addiction Therapy using Anisotropic Nanocrystals. Theranostics 2: 695-704.
34. Sheridan C (2012) Proof of concept for next-generation nanoparticle drugs in humans. Nat Biotechnol 30: 471-473.
35. Iversen F, Yang C, Dagnaes-Hansen F, Schaffert DH, Kjems J, et al. (2013) Optimized siRNA-PEG conjugates for extended blood circulation and reduced urine excretion in mice. Theranostics 3: 201-209.
36. Yigit MV, Moore A, Medarova Z (2012) Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res 29: 1180-1188.
37. Nichols B (2003) Caveosomes and endocytosis of lipid rafts. J Cell Sci 116: 4707-4714.
38. Poteryaev D, Datta S, Ackema K, Zerial M, Spang A (2010) Identification of the switch in early-to-late endosome transition. Cell 141: 497-508.
39. Chen AK, Behlke MA, Tsourkas A (2008) Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA. Nucleic Acids Res 36: e69.
40. Medley CD, Drake TJ, Tomasini JM, Rogers RJ, Tan W (2005) Simultaneous monitoring of the expression of multiple genes inside of single breast carcinoma cells. Anal Chem 77: 4713-4718. (Pubitemid 41076658)
41. Tsourkas A, Behlke MA, Bao G (2003) Hybridization of 2′-O-methyl and 2′-deoxy molecular beacons to RNA and DNA targets. Nucleic Acids Res 31: 5168-5174. (Pubitemid 36033035)
42. Yang CJ, Wang L, Wu Y, Kim Y, Medley CD, et al. (2007) Synthesis and investigation of deoxyribonucleic acid/locked nucleic acid chimeric molecular beacons. Nucleic Acids Res 35: 4030-4041. (Pubitemid 47244624)
43. Catrina IE, Marras SA, Bratu DP (2012) Tiny molecular beacons: LNA/2′-Omethyl RNA chimeric probes for imaging dynamic mRNA processes in living cells. ACS Chem Biol 7: 1586-1595.
44. He XX, Wang K, Tan W, Liu B, Lin X, et al. (2003) Bioconjugated nanoparticles for DNA protection from cleavage. J Am Chem Soc 125: 7168-7169. (Pubitemid 36798952)
45. Wang H, Yang R, Yang L, Tan W (2009) Nucleic acid conjugated nanomaterials for enhanced molecular recognition. ACS Nano 3: 2451-2460.
46. Shin SJ, Beech JR, Kelly KA (2013) Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer. Integr Biol (Camb) 5: 29-42.